The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
HemaSphere
(Aug 2023)
PB2224: ABBV-744 ALONE OR IN COMBINATION WITH RUXOLITINIB OR NAVITOCLAX IN PATIENTS WITH MYELOFIBROSIS: A PHASE 1B STUDY
John Mascarenhas,
Lei He,
Rabih Saab,
Nashat Gabrail,
Keita Kirito,
Deanna Brackman,
Federico Innocenti
Affiliations
John Mascarenhas
1 Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, United States
Lei He
2 AbbVie Inc, Chicago, United States
Rabih Saab
2 AbbVie Inc, Chicago, United States
Nashat Gabrail
3 Gabrail Cancer Center, Department of Oncology, Canton, United States
Keita Kirito
4 University of Yamanashi, Department of Hematology and Oncology, Kofu, Japan
Deanna Brackman
2 AbbVie Inc, Chicago, United States
Federico Innocenti
2 AbbVie Inc, Chicago, United States
DOI
https://doi.org/10.1097/01.HS9.0000975640.82589.03
Journal volume & issue
Vol. 7
p. e8258903
Abstract
Read online
No abstracts available.
WeChat QR code
Close